Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib
Oncology - Switzerland
doi 10.1159/000430989
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
S. Karger AG